CClinicalTrials.gg
CompletedNCT02969694HYPERCHEMUpdated Dec 19, 2025

Evaluation of Relationship Between Hypersexuality and Psychostimulant Among Men Who Have Sex With Men

An observational study in Psychoactive Substances Consumers, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-19.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
55
Ages
18 Years and older
Sex
Male
01

Study summary

Survey of fifty new psychoactive substances consumers in a context of MTM sexual intercourse.

Evaluation using an hetero-assessment questionnaire about the link between hypersexual disorder and the use of synthetic cathinone.

Evaluation on psychoactive drug addiction, the induced or pre-existing sexual practices and the medico-psycho-social consequences of those practices.

02

Conditions studied

  • Psychoactive Substances Consumers

Browse trials for

Keywords

  • addiction
  • hypersexuality
  • psychostimulants
03

In context

Behavior, Addictive

541 studies on the registry are indexed under Behavior, Addictive; 135 are open to participants now.

This study's enrollment of 55 is below the median of 170 across 133 observational studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

men who have sex with men and who take psychostimulants products in sexual contexts

Inclusion criteria

  • Patients ≥ 18 years

    • Male homosexual and / or bisexual who come to the CSAPA at the Croix-Rousse Hospital, Lyon France following the use of psychostimulants products in sexual contexts
    • Patients who have received clear information and not opposed to participate in the study
    • Patients affiliated to a social security scheme or similar
    • Patients not undergoing a measure of legal protection

Exclusion criteria

  • Opposition to participation in the study

    • Patients \< 18 years
    • Pregnant women or breastfeeding
    • Deprived of individual liberty
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
55 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients who use psychostimulants products in sexual contexts

    Patients who come to the CSAPA at the Croix-Rousse Hospital, Lyon France following the use of psychostimulants products in sexual contexts.These patients come for an addictologique support. The patients will answer to the G-STAT questionnaire.

    Other: G-STAT questionnaire

Interventions

  • OtherG-STAT questionnaire

    Patients will have a consultation with an addiction specialist physician. During the consultation, the physician ask the patient about these sexual practice and the use of psychostimulants. The patient will answer to the G-STAT questionnaire. This questionnaire allows the physician to perform an initial assessment of the patient's sexual addiction. The entire consultation takes place in the usual practice of consultations for this addiction.

06

What researchers measure

Primary outcomes

  1. G-STAT questionnaire

    Determine whether there are elements sexual addiction or if its elements are induced by the specific use of psychostimulants. The determination will be made using the interrogation conducted during the CSAPA consultation and G-STAT questionnaire.

    Time frame: Day 0

07

Study locations

1 site
  • Hospices Civils de Lyon
    Lyon, 69004, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02969694
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Nov 21, 2016
Start date
Sep 2016
Primary completion
Apr 2017
Completion
Apr 2017
Last update
Dec 19, 2025

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion